Option Care Health, Inc. announced preliminary unaudited financial results for Q4 and FY 2025 alongside financial guidance for FY 2026.
Fourth quarter 2025 expected results include net revenue of $1.46-$1.47 billion and adjusted EBITDA of $123.7-$127.7 million.
Full year 2025 anticipated results consist of net revenue between $5.645-$5.655 billion and adjusted EBITDA of $469.0-$473.0 million.
Preliminary financial guidance for 2026 includes net revenue of $5.8-$6.0 billion and adjusted EBITDA of $480-$505 million.
Financial Performance
Strong financial results expected for both Q4 2025 and full year 2025, with revenue and EBITDA growth.
Share Repurchase Program
Board of Directors authorized an increase in the share repurchase program to $1.0 billion, reflecting confidence in the company's performance.
Investor Conference Participation
Option Care Health will be participating in the 44th Annual J.P. Morgan Healthcare Conference, showcasing its market presence.
- The positive financial outlook for 2026 indicates continued growth and stability in Option Care Health's operations.
- The expanded share repurchase program reflects a strong commitment to returning value to shareholders and confidence in future prospects.
Option Care Health's robust financial results and strategic initiatives position it for growth and shareholder value creation in 2026.